COVID-19 Prevention Trial: Effect of Prophylactic Use of TAFFIX™ on Infection Rate by SARS-CoV-2 Virus (COVID-19).

NCT05252468 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

693

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
Upper Respiratory Tract Infections

Interventions

DEVICE: TaffiX™

Sponsor

Nasus Pharma